Subsequent events (Details) - Subsequent events - Ji Xing Pharmaceuticals $ in Millions |
May 15, 2021
USD ($)
|
|---|---|
| Subsequent events | |
| Upfront payment | $ 15 |
| Equity investment | $ 5 |
| X | ||||||||||
- Definition An upfront payment from a license and collaborative agreement. No definition available.
|
| X | ||||||||||
- Definition This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|